Skip to main content
. Author manuscript; available in PMC: 2018 Feb 1.
Published in final edited form as: Crit Care Med. 2017 Feb;45(2):e213–e221. doi: 10.1097/CCM.0000000000002075

Figure 7. NK-1R antagonist treatment reduces vascular leak into the intestines.

Figure 7

Vascular leak was measured by albumin extravasation into the intestine 24 hours after CLP. Mice subjected to CLP had increased vascular leak compared to naïve mice (dotted horizontal line). Treatment with NK-1R significantly prevented this vascular leak. *=p<.05 vehicle vs NK-1RA.